JP2005534672A5 - - Google Patents

Download PDF

Info

Publication number
JP2005534672A5
JP2005534672A5 JP2004514761A JP2004514761A JP2005534672A5 JP 2005534672 A5 JP2005534672 A5 JP 2005534672A5 JP 2004514761 A JP2004514761 A JP 2004514761A JP 2004514761 A JP2004514761 A JP 2004514761A JP 2005534672 A5 JP2005534672 A5 JP 2005534672A5
Authority
JP
Japan
Prior art keywords
oxy
phenyl
pyridinyl
acetic acid
pentyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004514761A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005534672A (ja
Filing date
Publication date
Priority claimed from GBGB0214149.7A external-priority patent/GB0214149D0/en
Application filed filed Critical
Publication of JP2005534672A publication Critical patent/JP2005534672A/ja
Publication of JP2005534672A5 publication Critical patent/JP2005534672A5/ja
Pending legal-status Critical Current

Links

JP2004514761A 2002-06-19 2003-06-18 hPPAR活性化物質としてのフェニルアルカン酸及びフェニルオキシアルカン酸誘導体 Pending JP2005534672A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0214149.7A GB0214149D0 (en) 2002-06-19 2002-06-19 Chemical compounds
PCT/EP2003/006415 WO2004000315A1 (en) 2002-06-19 2003-06-18 Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as hppar activators

Publications (2)

Publication Number Publication Date
JP2005534672A JP2005534672A (ja) 2005-11-17
JP2005534672A5 true JP2005534672A5 (https=) 2006-06-15

Family

ID=9938916

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004514761A Pending JP2005534672A (ja) 2002-06-19 2003-06-18 hPPAR活性化物質としてのフェニルアルカン酸及びフェニルオキシアルカン酸誘導体

Country Status (25)

Country Link
US (1) US7338960B2 (https=)
EP (1) EP1513526B1 (https=)
JP (1) JP2005534672A (https=)
KR (1) KR20050030624A (https=)
CN (1) CN1674897A (https=)
AT (1) ATE377420T1 (https=)
AU (1) AU2003245962B2 (https=)
BR (1) BR0311931A (https=)
CA (1) CA2487909A1 (https=)
CY (1) CY1107168T1 (https=)
DE (1) DE60317326T2 (https=)
DK (1) DK1513526T3 (https=)
ES (1) ES2295601T3 (https=)
GB (1) GB0214149D0 (https=)
IL (1) IL165476A0 (https=)
IS (1) IS7574A (https=)
MX (1) MXPA04012857A (https=)
NO (1) NO20045328L (https=)
NZ (1) NZ537210A (https=)
PL (1) PL375148A1 (https=)
PT (1) PT1513526E (https=)
RU (1) RU2323929C2 (https=)
SI (1) SI1513526T1 (https=)
WO (1) WO2004000315A1 (https=)
ZA (1) ZA200410061B (https=)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7244763B2 (en) 2003-04-17 2007-07-17 Warner Lambert Company Llc Compounds that modulate PPAR activity and methods of preparation
EP1667964B1 (en) 2003-09-19 2009-07-22 Janssen Pharmaceutica N.V. 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
CN1875002B (zh) 2003-11-05 2011-08-03 霍夫曼-拉罗奇有限公司 作为ppar激动剂的苯基衍生物
AU2004309271A1 (en) 2003-12-25 2005-07-14 Takeda Pharmaceutical Company Limited 3-(4-benzyloxyphenyl)propanoic acid derivatives
JP5299810B2 (ja) * 2004-02-27 2013-09-25 アムジエン・インコーポレーテツド 代謝疾患の治療に使用するための、化合物、薬学的組成物及び方法
AR048523A1 (es) * 2004-04-07 2006-05-03 Kalypsys Inc Compuestos con estructura de aril sulfonamida y sulfonilo como moduladores de ppar y metodos para tratar trastornos metabolicos
DE602005024384D1 (de) 2004-05-05 2010-12-09 High Point Pharmaceuticals Llc Neue verbindungen, ihre herstellung und verwendung
US8053598B2 (en) 2004-05-05 2011-11-08 High Point Pharmaceuticals, Llc Compounds, their preparation and use
MY147518A (en) 2004-09-15 2012-12-31 Janssen Pharmaceutica Nv 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
US7465804B2 (en) * 2005-05-20 2008-12-16 Amgen Inc. Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders
ES2372617T3 (es) 2005-06-30 2012-01-24 High Point Pharmaceuticals, Llc Ácidos fenoxiacéticos como activadores de ppar-delta.
JO3006B1 (ar) 2005-09-14 2016-09-05 Janssen Pharmaceutica Nv املاح ليسين مبتكرة من مشتقات حامض 4-((فينوكسي الكيل)ثيو) فينوكسي الخليك
WO2007033002A1 (en) 2005-09-14 2007-03-22 Amgen Inc. Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
CN103224477A (zh) 2005-12-22 2013-07-31 高点制药有限责任公司 作为PPAR-δ活化剂的苯氧基乙酸
US7943612B2 (en) 2006-03-09 2011-05-17 High Point Pharmaceuticals, Llc Compounds that modulate PPAR activity, their preparation and use
CA2646430A1 (en) * 2006-03-14 2007-09-20 Amgen Inc. Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
UY30288A1 (es) 2006-04-18 2007-08-31 Janssen Pharmaceutica Nv Derivados del ácido benzoazepin-oxi-acético como agonistas de ppar-delta usados para aumentar hdl-c. reducir ldl-c y reducir colesterol
CN101591227B (zh) * 2006-06-23 2012-09-05 赵昱 一类肉桂醇类衍生物及其制备方法和药物用途
CA2662305C (en) 2006-09-07 2012-04-17 Amgen Inc. Heterocyclic gpr40 modulators
AU2007292816B2 (en) * 2006-09-07 2011-11-17 Amgen Inc. Benzo-fused compounds for use in treating metabolic disorders
US8519145B2 (en) 2006-12-02 2013-08-27 Seoul National University Industry Foundation Aryl compounds as PPAR ligands and their use
EP2139843B1 (en) 2007-04-16 2013-12-25 Amgen, Inc Substituted biphenyl phenoxy-, thiophenyl- and aminophenylpropanoic acid gpr40 modulators
JP5291708B2 (ja) * 2007-07-25 2013-09-18 中国人民解放軍軍事医学科学院毒物薬物研究所 アリールピリミジン誘導体、その製造方法、及び、その使用
CN102083783A (zh) 2007-10-10 2011-06-01 安姆根有限公司 取代的联苯gpr40调节剂
WO2009111056A1 (en) * 2008-03-06 2009-09-11 Amgen Inc. Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders
AU2009303475B2 (en) * 2008-10-15 2012-09-13 Amgen Inc. Spirocyclic GPR40 modulators
EP2699569B1 (en) * 2011-04-22 2017-08-30 Jasco Pharmaceuticals, LLC Aminopyrimidine kinase inhibitors
NZ631569A (en) 2012-02-28 2016-10-28 Piramal Entpr Ltd Phenyl alkanoic acid derivatives as gpr agonists
KR101569522B1 (ko) 2013-04-18 2015-11-17 현대약품 주식회사 신규한 3-(4-(벤질옥시)페닐)헥스-4-이노익 산 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 대사성 질환의 예방 또는 치료용 약학적 조성물
EP3756661A1 (en) 2013-09-09 2020-12-30 vTv Therapeutics LLC Use of a ppar-delta agonist for treating muscle atrophy
CN108503581A (zh) * 2018-04-12 2018-09-07 苏州康润医药有限公司 一种3-溴-6-氟-2-吡啶乙酮的合成方法
WO2023147309A1 (en) 2022-01-25 2023-08-03 Reneo Pharmaceuticals, Inc. Use of ppar-delta agonists in the treatment of disease

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS175831B1 (https=) * 1974-12-17 1977-05-31
FR2401459A1 (fr) * 1977-08-26 1979-03-23 Cii Honeywell Bull Support d'information portatif muni d'un microprocesseur et d'une memoire morte programmable
DE4038335A1 (de) * 1990-12-01 1992-06-04 Boehringer Mannheim Gmbh Neue pyridinderivate, verfahren zu ihrer herstellung und verwendung als arzneimittel
GB9604242D0 (en) * 1996-02-28 1996-05-01 Glaxo Wellcome Inc Chemical compounds
US6204277B1 (en) * 1996-08-19 2001-03-20 Japan Tobacco Inc. Propionic acid derivatives and applications thereof
WO1999011255A1 (en) * 1997-08-28 1999-03-11 Ono Pharmaceutical Co., Ltd. Peroxisome proliferator-activated receptor controllers
ATE451346T1 (de) * 1998-03-10 2009-12-15 Ono Pharmaceutical Co Carbonsäurederivate und medikamente die diese als aktiven wirkstoff enthalten
US6586475B1 (en) * 1998-11-20 2003-07-01 Takeda Chemical Industries, Ltd. β-amyloid protein production/secretion inhibitors
EP1177176B1 (en) * 1999-04-28 2006-04-19 Aventis Pharma Deutschland GmbH Tri-aryl acid derivatives as ppar receptor ligands
WO2001036351A2 (en) * 1999-11-19 2001-05-25 Corvas International, Inc. Plasminogen activator inhibitor antagonists related applications
CN1251671C (zh) * 2000-05-19 2006-04-19 武田药品工业株式会社 β分泌酶抑制剂

Similar Documents

Publication Publication Date Title
JP2005534672A5 (https=)
RU2323929C2 (ru) Производные фенилалкановой кислоты и фенилоксиалкановой кислоты, их применение и содержащая их фармацевтическая композиция
JP2007502806A5 (https=)
RU2312105C2 (ru) N-пиразинилфенилсульфонамиды и их применение при лечении опосредованных хемокинами заболеваний
NZ542072A (en) Compounds for the treatment of metabolic disorders
JP2005509590A5 (https=)
JP2009541270A5 (https=)
JP2007511485A5 (https=)
RU2006107653A (ru) Связующее вспомогательное вещество и приготовленная на его основе таблетка в форме капли
JP2021516240A5 (https=)
RU2004137092A (ru) Производные пропионовых кислот и их применение в качестве активаторов hppars.
JP2009541269A5 (https=)
JP2005534673A5 (https=)
JP2006518763A5 (https=)
JP2004518702A5 (https=)
JP2004532227A5 (https=)
RU2009148304A (ru) Модуляторы гидролазы амидов жирных кислот на основе гетероарилзамещенной мочевины
JP2004534035A5 (https=)
JP2013513605A5 (https=)
JP2007525516A5 (https=)
IL320810A (en) Glucagon-like peptide 1 receptor agonists
MXPA01001047A (es) Ligandos receptores de glucocorticoide y hormona de tiroides para el tratamiento de desordenes metabolicos.
JP2005521650A5 (https=)
JP2013531070A5 (https=)
JP2006526596A5 (https=)